Report copyright - Review - Food and Drug Administration · 2021. 1. 7. · NDA/BLA Multi-disciplinary Review and Evaluation: NDA 214, 621 Relugolix 4 Version date: January 2020 (ALL NDA/ BLA reviews)
Please pass captcha verification before submit form